Discover the Power
of ACROSS Partnerships

Partner with us to access global innovation, leverage local expertise, and collaborate with industry leaders to accelerate clinical research and achieve impactful results together.

Explore Our Global
Network of Trusted Partners

ACROSS Global Alliance brings together a diverse network of leading clinical research organizations and industry experts. Explore our trusted partners who contribute to advancing innovation and excellence in clinical research worldwide.

Global CRO Coverage

Global CRO Coverage - 2GL Outsourcing

Discover More

Global CRO Coverage - Activa

Discover More

Global CRO Coverage - Balsam_CR

Discover More

Global CRO Coverage - ClinActis

Discover More

Global CRO Coverage - Clinica

Discover More

Global CRO Coverage - Beijing Clinical Service Center

Discover More

Global CRO Coverage - GLSA

Discover More

Global CRO Coverage - Guosa Life Sciences

Discover More

Global CRO Coverage - micron

Discover More

Global CRO Coverage - OrciTrials

Discover More

Global CRO Coverage - Pharma Clinical

Discover More

Global CRO Coverage - Phaze Clinical

Discover More

Global CRO Coverage - Phoenix Clinical Research

Discover More

Global CRO Coverage - Research Professionals

Discover More

Global CRO Coverage - SRG

Discover More

Global CRO Coverage - Verum

Discover More

Specialist Service Providers (SSPs)

Specialist Service Provider - Avanti

Discover More

Specialist Service Provider - ConsilX

Discover More

Specialist Service Provider - IRM

Discover More

Specialist Service Provider - LabFish

Discover More

Specialist Service Provider - Wemedoo

Discover More

Executive Committee Members

Alliance Model Benefits

Why Engage With Us?

ACROSS Global Alliance offers a proven framework for collaboration, empowering clinical research companies to expand their reach, optimize operations, and achieve exceptional outcomes. Discover the key benefits of our global network.

Across Global Alliance - Infographic_2

Efficiently Managing Clinical Trials from Start to Finish

Real-Time Impact:
How the Alliance Delivers Results

Rapid Proposals

Generate tailored project proposals quickly with our advanced technology. Streamline planning and execution to support your clinical trial goals efficiently, ensuring timely delivery and helping your projects stay on schedule.

Accelerated Recruitment

Reach diverse demographics quickly with our expansive global network. Our tailored recruitment strategies ensure optimal participant enrollment, reducing timelines and supporting the success of your clinical trials.

Proven Efficiency

Streamline your clinical trials with an integrated approach that eliminates the need for third-party systems. Seamless connections to external tools ensure real-time data flow, enhancing accuracy, reducing delays, and driving operational excellence.

Partner With Us
to Advance Clinical Research

Connect with us today to explore how we can help bring your innovative research to life

2GL Outsourcing

Established in 2008, 2GL Outsourcing has earned a reputation as a trusted leader in providing innovative outsourcing solutions across diverse industries. With a foundation built on longstanding collaborations with both international and domestic partners, the company leverages its extensive expertise to deliver exceptional value to its clients.

Specializing in tailored solutions, 2GL Outsourcing addresses complex business challenges in sectors such as Information Technology (IT), Contract Research Organizations (CROs), and pharmaceuticals. As a proud member of the ACROSS Global Alliance, the company is dedicated to delivering exceptional service quality, consistently adapting to the dynamic needs of its clients and industries.

ACTIVA

ACTIVA CRO is a full-service expert Contract Research Organization (CRO) with operations in Latin America, who provides the CRO, Biotech, Pharmaceutical, and Medical Device Industry with a range of services related to the clinical development of healthcare products and solutions.

ACTIVA CRO brings today a vast number of projects-experience in all Clinical trial phases and major therapeutic indications, including Oncology, Hematology, Cardiovascular, Orphan Diseases, CNS, First in Human, and Pivotal studies in Medical Devices, with senior project managers that bring an average of 10 years of experience gained in CROs and Pharmaceutical companies.

ACTIVA CRO considers itself an expert Pharma, Biotech, and Medical Device CRO company, offering personalized high quality clinical research services.

We endeavor to satisfy our clients & partners requirements and expectations by working closely with them to facilitate the efficient management of their projects and the success is traduced to establish long strong relationships with our business partnerships.

Balsam

Balsam Clinical Research, founded in 2021 in Saudi Arabia, is a full-service Contract Research Organization (CRO) accredited by the Saudi FDA.

They offer comprehensive services, including medical writing, biostatistics, project management, clinical operations, and regulatory support, tailored to the unique needs of the Middle East and North Africa (MENA) region.

Renowned for their quality deliverables, Balsam CR aims to bring Swiss standards to Middle Eastern clinical research.

Their commitment to transparency, quality, commitment, and efficiency has established them as a trusted partner in advancing healthcare innovations across the region.

ClinActis

ClinActis is a Singapore-based, full-service CRO, founded in 2009, specializing in clinical research across Asia Pacific (APAC). Our team combines deep local expertise in APAC with extensive experience managing multi-region and global trials that meet international quality standards for major regulatory agencies like the FDA and EMA.

With a senior management team boasting over 50 years of cumulative experience, we offer comprehensive clinical trial solutions including clinical project management, site management, clinical monitoring, data management, biostatistics, and medical writing.

ClinActis operates in key APAC countries and territories including Singapore, South Korea, China, Taiwan, Hong Kong, the Philippines, Malaysia, Thailand, Japan, India, Australia, and New Zealand.

Our commitment to international quality standards, local expertise, and cost-effective clinical trial services has made us a trusted CRO partner for biotech, pharmaceutical, medical device, and medical nutrition companies aiming to take advantage of the benefits of conducting clinical trials in APAC and accelerate their clinical development programs in this dynamic region.

CLINICA Research Solutions

CLINICA Research Solutions LLP, based in Navi Mumbai, India is a full-service Clinical Research Organization (CRO) specializing in human studies.

They offer comprehensive services to pharmaceuticals, AYUSH, nutraceuticals, cosmeceuticals, biotechnology, medical diagnostics, and medical device companies, supporting both pre- and post-approval clinical development strategies.

With over three decades of experience, CLINICA’s expert team has successfully conducted hundreds of studies, demonstrating proficiency in clinical operations, data management, biostatistics, quality assurance, medical writing, and consulting.

Their commitment to quality and client-focused approach positions them as a reliable partner in advancing healthcare innovations.

Clinical Service Center

Clinical Service Center (CSC), headquartered in Beijing, China, is a comprehensive medical technology service provider specializing in clinical trials, regulatory registration, medical writing, biostatistics and data management, quality assurance, training, and consulting services.

With physical offices in cities such as Shanghai, Guangzhou, Chengdu, Xi’an, Shenyang, Suzhou, and Nanjing, and a presence in over 20 other cities, CSC offers extensive coverage across China.

Their commitment to quality and comprehensive service offerings make them a trusted partner in advancing clinical research and development within the region.

Global Life Sciences Alliance | GLSA

Global Life Sciences Alliance (GLSA) is a dynamic network of global Contract Research Organizations (CROs) and clinical research vendors dedicated to providing innovative clinical trial solutions for Sponsors and CROs.

With over 100 years of combined experience, GLSA offers comprehensive services, including vendor selection and oversight, patient recruitment and retention, and site contracts and negotiations.

Their global reach and collaborative approach ensure tailored solutions that accelerate clinical trial timelines and enhance research quality.

By connecting sponsors with the right CROs, GLSA propels clinical trials into the future, fostering partnerships that drive value and success.

Guosa Life Sciences

Guosa Life Sciences (GLS) is a specialty Contract Research Organization (CRO) with a strong presence in both the United States and Sub-Saharan Africa.

They offer comprehensive drug development lifecycle management solutions to pharmaceutical, biotechnology, medical device, academic, government, and non-governmental organizations.

With regional offices in the U.S., Kenya, Ghana, and Nigeria, GLS is adept at navigating the complexities of both developed and emerging markets.

Their commitment to patient safety, quality, and cost-effective services makes them a trusted partner in advancing global healthcare initiatives.

Micron

Micron, Inc. is a specialized imaging CRO (iCRO) with almost 20 years of experience in managing imaging for clinical trials globally, including the Asia Pacific region. They offer comprehensive imaging services tailored to the unique needs of each trial, ensuring regulatory rigor and high-quality data.

With a track record of supporting over 250 customers and contributing to the market introduction of more than 40 drugs, Micron’s expertise spans various therapeutic indications, imaging modalities, and assessment criteria. Also, they offer a wide variety of services for overseas sponsors planning to conduct clinical trials in Japan, not limited to ICCC (In Country Clinical Care – taker) services, but also MAH/DMAH, sales and distribution services to support our clients’ needs. Their commitment to customer satisfaction and cultural adaptability makes them a trusted partner in the clinical research industry.

OrciTrials

OrciTrials is a premium Contract Research Organization (CRO) with offices in Pakistan, the United Kingdom, and Singapore, serving clients globally.

With a leadership team boasting over 70 years of cumulative experience, they offer specialized clinical research services across all therapeutic areas and phases of clinical development.

Their comprehensive services include clinical trial solutions, quality assurance, real-world evidence studies, and global remote services, all tailored to meet each client’s unique needs.

Committed to collaboration, flexibility, and passion, OrciTrials strives to increase patient access to next-generation therapies through creative and flexible clinical research solutions.

Pharma Clinical

Pharma Clinical S.A.G. (2003) Ltd, established in 1988 and headquartered in Ness Ziona, Israel, is an independent Contract Research Organization (CRO) offering a comprehensive range of clinical development services.

With over 35 years of experience, their team of 30 passionate professionals has successfully conducted over 300 Phase I-IV and observational clinical studies across various therapeutic areas, including cardiovascular and oncology.

Pharma Clinical provides end-to-end services such as study design and planning, data management, biostatistics, medical writing, monitoring, and project management, ensuring high-quality, tailor-made solutions for their clients.

Their deep understanding of the Israeli regulatory landscape, combined with strong relationships with key opinion leaders and robust project management capabilities, optimize clinical operations and ensure timely delivery while meeting sponsors’ expectations.

Phaze Clinical

Phaze S.A., established in April 2010 and headquartered in Athens, Greece, is a distinguished Contract Research Organization (CRO) offering a comprehensive suite of clinical research services.

Their expertise encompasses project management, clinical monitoring, safety and pharmacovigilance, data management, biostatistics, market research, medical writing, and medical/scientific translations.

Committed to delivering high-quality, tailor-made solutions, Phaze collaborates with pharmaceutical and biotechnology companies, as well as other CROs and research institutions, to advance clinical development programs.

As a founding member of the Hellenic Association of CROs and an ISO 9001:2015 certified organization, Phaze upholds the highest standards of quality and ethical conduct in all their endeavors.

Phoenix Clinical Research

Phoenix Clinical Research (Phoenix CR), headquartered in Beirut, Lebanon, with Offices in Saudi Arabia, United Arab Emirates, Egypt and Tunisia, is a dynamic full-service Contract Research Organization (CRO) dedicated to advancing clinical research across the Middle East and North Africa (MENA) region.

With over 21 years of international and regional expertise, Phoenix CR offers comprehensive services including clinical operations, medical writing, biostatistics, project management, and pharmacovigilance.

Their commitment to transparency, quality, commitment, and efficiency ensures top-tier results tailored to each client’s unique needs.

As an ISO-accredited organization, Phoenix CR upholds the highest standards, making them a trusted partner for pharmaceutical and biotechnology companies aiming to conduct clinical trials in the MENA region.

Research Professionals

Research Professionals CRO (RP-CRO), headquartered in Budapest, Hungary, is a leading Good Clinical Practice (GCP) compliant Contract Research Organization (CRO) with operations extending across Poland, Czechia, Romania, Bulgaria, and Serbia.

Specializing in comprehensive clinical research management services, RP-CRO leverages an extensive network of experienced Principal Investigators (PIs) and large local subject pools to accelerate study enrollment across diverse therapeutic areas.

Their commitment to quality is underscored by robust quality systems adhering to GCP regulations and a CenterWatch-based Quality Management System (QMS), ensuring high-quality clinical trial submissions to global regulatory bodies, including the U.S. FDA and EMA.

As the founder of ACROSS Global™, a strategic alliance of CROs covering 99 countries, RP-CRO offers clients access to more than 8,835 study sites worldwide, exemplifying their dedication to efficient, flexible, and high-quality clinical research solutions.

Synergy Research Group

Synergy Research Group (SRG), established in 2002, is a Russian full-service Contract Research Organization (CRO) with over 20 years of experience in conducting clinical trials and registering medicines and medical devices across Russia, Kazakhstan, and other EAEU and CIS countries.

With over 420 completed projects spanning more than 40 therapeutic areas, SRG offers comprehensive services including feasibility assessment, medical writing, project management, clinical, medical, medical, and centralized monitoring, data management, biostatistics, regulatory support, and quality assurance.

Their team comprises 58 professionals on staff, including eight PhDs and 33 medical doctors or pharmacists, ensuring high-quality and reliable clinical research outcomes.

As a founding partner of ACROSS Global Alliance, SRG provides clients access to an extensive network of over 8,835 accredited medical institutions worldwide, facilitating international clinical trial collaborations.

Verum.de

Verum is a seasoned Contract Research Organization (CRO) with over 25 years of experience in managing clinical trials across Europe.

Headquartered in Munich, Germany, they have successfully conducted more than 160 studies involving over 30,000 subjects.

Their comprehensive services include clinical trial management, regulatory affairs, data management, GCP audits, medical writing, and monitoring, catering to therapeutic areas such as cardiology, oncology, hematology, neuroscience, psychiatry, respiratory and infectious diseases, endocrinology, dermatology, and reproductive care medicine.

With a highly educated team, 80% of whom are academics or physicians, Verum ensures the highest standards of quality and reliability in clinical research.

Avanti PC

Avanti Services and Solutions, founded in 2009 in São Paulo, Brazil, is a leading Latin American Academic Research Organization (ARO) integrating CRO services with specialized sourcing of comparative drugs and medical devices. Avanti supplies research sites with medical devices for sales, rental, calibration, validation, maintenance, and metrology compliance.

Serving all Latin America through alliances, Avanti manages Phase I-IV trials, RWE, and DCT, offering project management, site/regulatory expertise, monitoring, data management, and pharmacovigilance. Strong university collaborations make Avanti the region’s top ARO. With rapid medical device delivery (24-48 hours) and extensive calibration networks, Avanti ensures efficient, high-quality clinical research for pharma, biotech, and medical device companies. Through its senior leadership and vast experience in the pharmaceutical industry, Avanti is a reliable and trusted partner with HQs in Brazil, the largest and most experienced country for clinical trials in Latin America.

ConsilX

Consilx Digital, a technology platform provider for clinical trials strive to optimize the long, expensive clinical trial processes to improve efficiency and effectiveness, and enabling next generation trials, including virtual/digital trials.

Consilx’s platforms (eConsent, patient engagement, EDC, Direct data capture, and Telemedicine), digitize critical aspects of drug development, connect patients with clinical site personnel, facilitate tele-conduct and remote data collection from variable sources such as wearables, devices, PROs, etc.

IRM Europe

IRM supports all stakeholders in clinical research, including patients, clinical sites, CROs, Sponsors, and global Functional Service Providers, with a focus on achieving successful and timely project delivery.

Their expertise spans patient travel and transportation, sourcing and rental of medical equipment and ancillary materials, establishing clinical trial referral networks for patient recruitment, importer of record (IoR) services, and strategic consulting.

At IRM , we are dedicated to delivering tailored solutions that streamline clinical research operations, ensuring efficiency and excellence at every stage of the project lifecycle.

LABFISH Clinical Trial Supplies

LABFISH Rental Solutions GmbH specializes in providing comprehensive laboratory equipment rental and support services for clinical trials.

Their offerings include a wide range of products such as centrifuges, refrigerators, freezers, and more, all tailored to meet the specific needs of clinical research.

With a commitment to quality and flexibility, LABFISH ensures that all equipment undergoes a rigorous qualification process to meet general regulations and CE conformity standards.

Their services encompass calibration, clinical trial monitoring, and white-glove shipping, providing end-to-end solutions for successful clinical trials.

Wemedoo

Wemedoo AG is a Swiss company at the forefront of medical innovation, seamlessly merging clinical practice and research through the integration and standardization of clinical data. Our AI-powered solutions streamline clinical data management through interoperability, ensuring efficiency, compliance, and seamless collaboration between CROs, sponsors, and research teams.

With a centralized infrastructure, Wemedoo eliminates data silos, reduces manual work, and accelerates trial timelines while maintaining regulatory excellence. We empower CROs to work smarter, not harder, by providing real-time insights, automated workflows, and risk-based monitoring to enhance trial efficiency.

At Wemedoo, we don’t just provide solutions – we help CROs build trust with sponsors, optimize trial execution, and succeed in an increasingly complex research landscape

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Dr. Ajaykumar B Malle

Dr. Ajaykumar B Malle, the Chief Executive Officer of CLINICA Research Solutions LLP, a highly regarded Clinical Research Organization based in Navi Mumbai, India that is dedicated to expediting the development of groundbreaking healthcare solutions. Boasting an impressive career spanning over 22 years in the pharmaceutical, biotechnology, and clinical research industries, Dr. Malle has consistently demonstrated his ability to drive growth, operational excellence, and strategic vision.

Under Dr. Malle’s guidance, CLINICA has solidified its reputation as a trusted partner for both Indian and global pharmaceutical companies, offering top-notch clinical trial management, regulatory consulting, and data analytics services. Driven by his commitment to innovation and customer-centricity, he is known for his exceptional talent in building strong, collaborative teams and fostering a culture of ingenuity.

Dr. Malle’s visionary perspective is centered around making clinical trials more efficient, patient-centered, and accessible, thus accelerating the availability of life-saving treatments. With his extensive expertise in clinical operations, data management, medical writing, regulatory strategy, medical monitoring and business development, he has played a pivotal role in successfully guiding numerous clinical programs from their early-phase development to achieving regulatory approval. Throughout his career, Dr. Malle has earned recognition for his profound understanding of the intricacies of clinical research, as well as his unwavering commitment to upholding the highest standards of scientific and ethical integrity.

Among his notable accomplishments, Dr. Malle holds an Bachelor of Medicine and Bachelor of Surgery (MBBS) degree, along with certifications in PMP®, Diploma in Marketing Management (DMkM), Professional Diploma in Clinical Research (PDCR), and Advanced Certificate Course in Clinical Project Management (ACCPM). He is a sought-after speaker at industry conferences, where he shares his insights on diverse topics related to clinical research innovation, regulatory strategy, and patient engagement. Prior to joining CLINICA Research Solutions LLP, Dr. Malle held influential leadership positions in multinational and domestic pharmaceutical companies, where he spearheaded global clinical operations, strategic development, and regulatory submissions for numerous prominent clinical trials.

Dr. Malle firmly believes that the trajectory of healthcare hinges on unwavering dedication to innovation and a sincere commitment to patients. His leadership philosophy is rooted in transparency, collaboration, and an unwavering passion to make a substantial impact on the lives of patients worldwide.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Galina Malakhova

Galina holds a Bachelor’s degree in Economics and has over 20 years of extensive experience in various executive positions. She has given last 15 years of dedicated work to Synergy. Having risen together with Synergy from company beginnings to a full service CRO with its own philosophy and vast experience, Galina played an important role in building processes, managing long-term partnerships with Synergy clients and partners.

Synergy is now a leading full service contract research organization (CRO) covering many countries. Synergy strives to build a synergetic relationship with every client using time-tested traditional solutions along with up to date risk-based, innovative, technological approaches for the conduct of clinical trials.

Spiros Anagnostopoulos

With more than 20 years of experience in clinical trials field Spiros Anagnostopoulos is the Founder and Managing Director of CRO Phaze Clinical Research & Pharma Consulting S.A. established on 2010 in Athens, Greece.

Biologist by profession, he has a broad experience of all aspects in CRO market starting as a Clinical Research Associate and gaining knowledge and experience from various positions within CROs industry.

Spiros also holds the positions of founding member of Hellenic Association of CROs and Vice President of its Board of Directors for the current term.

Christophe Tournerie

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Hiroaki Suzuki

Hiroaki Suzuki has more than 20 years of experience in clinical research. He started his career by joining a global medical device company in 1996. While working as a system engineer, Mr. Suzuki was involved in bringing several medical devices to the market. In 2000, he moved on to the clinical research field. As a project leader, he successfully led Urology, CNS, and Oncology studies. In 2005, as one of the founding members, Hiroaki Suzuki, helped launch Micron, the first Imaging Contract Research Organization in the Asia-Pacific region. At first, he was appointed a director, a clinical development manager, and a project manager of monitoring services. In 2008, he was involved in the establishment of Micron’s imaging service department as a manager.

Hiroaki Suzuki believes that medical imaging is one of the essential tools to further medical advancement. By setting imaging endpoints, pharmaceutical responses can be evaluated quantitatively, which shortens clinical trials and improves efficiency. Mr. Suzuki has been proactively working to adapt medical imaging technology to clinical trials.

Due to his efforts, Micron has grown to have the largest team of imaging experts in APAC and can support multiple sponsors globally.

Hualong Sun

Dr. Sun graduated from University of Tokyo. He has more than 18 years’ experience in the leading pharmaceutical and CRO industry, e.g. Merck Serono and PAREXEL.

Dr. Sun has extensive experience in clinical trials, especially in data management. His study experience varies across phase I-IV in fields of Oncology, Psychiatry, Gastroenterology, Infectious Disease, and Medical Devices.

Dr. Sun is a well-known expert in clinical trials in China, and he has been actively promoting the development of clinical trials industry in China. He is the core member of China Clinical Data Management Working Group, Member of Advisory Consultation Committee(ACC) and DIA China.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Limor Rozner

Limor Rozner is the Business Development Manager and a Project Manager at Pharma Clinical S.A.G (2003) Ltd.

Limor joined Pharma Clinical in 2013 with prior experience in Global pharmaceutical and CRO companies. She has 11 years of extensive experience in clinical trials management, leading multi-national phase II and III trials.In addition to her role as a Business Development Manager and Project Manager, she acts as the country Risk Based Monitoring

Limor holds a Bachelor of Science degree of Biotechnology from Ben-Gurion University of the Negev, Israel.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Oleksii Mikheiev M.D., Ph.D.

Dr. Oleksii Mikheiev is currently the Chief Executive Officer of verum.de GmbH and, former Verum Regional Managing Director at Cluster Verum Office in CIS Countries (1999-2017). From 2016 till 2018, he headed Clinical Trial Subcommittee of European Business Association (the biggest business community NGO in Ukraine). He joined Verum in 1998 after three years of experience as sub-investigator in phase II-III clinical trials. Totally he has 24 years of experience in clinical trials conduction, and, particularly, 20 years of experience in CRO general management. During last ten years Oleksii Mikheiev has been focused on business development, including creation and development of regional offices network. He manages the CRO with strong and sufficient experience of phase II-IV clinical trials set-up, conduction and follow-up, including several FDA inspections with positive outcomes. He was a member of working groups of Ministry of Health (Ukraine) for drafting the clinical trials legislation in Ukraine. He has experience of collaboration with international organizations (WHO, UNAIDS and UNICEF) as the temporary advisor.

Oleksiy Mykheev holds M.D. degree from the National Medical University in Kiev, Ukraine since 1994, received Ph.D. degree in medicine in 2000 and became associate professor in 2014.

Zoran Acimovic

Owner and CEO 2 GL Outsourcing and CRA Academy- Belgrade, Serbia. Zoran Aćimović holds an IT Master of Science. He has more than 25 years of experience in the IT industry and 15 years of experience in the field of health care and clinical trials. In 2011 Zoran co-founded the CRA Academy, which is the only institution in Serbia which educates professional personal working in clinical research and the pharmaceutical industry.

He has been an organizer of informal training for more than 15 years. As the CEO of 2 GL Outsourcing he can provided various services ranging from clinical trials to regulatory affairs, site and project management, quality assurance, HR management and IT management. He started new services in the ex-Yugoslavia (ex-Yu) region as Mobile Research Nurse and Clinical Site Coordinator. For ten years, he successfully organized conferences for clinical trials in Serbia and the Ex-Yu region.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.